Real-World Use of BTK Inhibitors in Chronic Lymphocytic Leukemia - Episode 2
Marc S. Hoffmann, MD, and Mazyar Shadman, MD, MPH, discuss how to use data for BTK inhibitors to inform clinical decisions in chronic lymphocytic leukemia.
Related Content: